Cancer Research Annual Meeting 2010  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hippo, Y.
Right arrow Articles by Aburatani, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hippo, Y.
Right arrow Articles by Aburatani, H.
[Cancer Research 61, 889-895, February 1, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

Differential Gene Expression Profiles of Scirrhous Gastric Cancer Cells with High Metastatic Potential to Peritoneum or Lymph Nodes1

Yoshitaka Hippo, Masakazu Yashiro, Masami Ishii, Hirokazu Taniguchi, Shuichi Tsutsumi, Kosei Hirakawa, Tatsuhiko Kodama and Hiroyuki Aburatani2

Genome Science Division [Y. H., M. I., H. T., S. T., H. A.], Division of Molecular Biology and Medicine [T. K.], Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo 153-8904, Japan, and First Department of Surgery, Osaka City University Medical School, Osaka 545-8586, Japan [M. Y., K. H.]


    ABSTRACT
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 
Scirrhous gastric cancer is often accompanied by metastasis to the peritoneum and/or lymph nodes, resulting in the highest mortality rate among gastric cancers. Mechanisms involved in gastric cancer metastasis are not fully clarified because metastasis involves multiple steps and requires the accumulation of altered expression of many different genes. Thus, independent analysis of any single gene would be insufficient to understand all of the aspects of gastric cancer metastasis. In this study, we performed global analysis on differential gene expression of a scirrhous gastric cancer cell line (OCUM-2M) and its derivative sublines with high potential for metastasis to the peritoneal cavity (OCUM-2MD3) and lymph nodes (OCUM-2MLN) in a nude mice model. By applying a high-density oligonucleotide array method, expression of approximately 6800 genes was analyzed, and selected genes were confirmed by the Northern blot method. In our observations in OCUM-2MD3 cells, 12 genes were up-regulated, and 20 genes were down-regulated. In OCUM-2MLN cells, five genes were up-regulated, and five genes were down-regulated. The analysis revealed two functional gene clusters with altered expression: (a) down-regulation of a cluster of squamous cell differentiation marker genes such as small proline-rich proteins [SPRRs (SPRR1A, SPRR1B, and SPRR2A], annexin A1, epithelial membrane protein 1, cellular retinoic acid-binding protein 2, and mesothelin in OCUM-2MD3 cells; and (b) up-regulation of a cluster of antigen-presenting genes such as MHC class II (DP, DR, and DM) and invariant chain (Ii) in OCUM-2MLN cells through up-regulation of CIITA (MHC class II transactivator). We then analyzed six gastric cancer cell lines by Northern blot and observed preferential up-regulation of trefoil factor 1, {alpha}-1-antitrypsin, and galectin 4 and down-regulation of cytidine deaminase in cells prone to peritoneal dissemination. Genes highly correlated with invasion or peritoneal dissemination of gastric cancer, such as E-cadherin or integrin ß4, were down-regulated in both of the derivative cell lines analyzed in this study. This is the first demonstration of global gene expression analysis of gastric cancer cells with different metastatic potentials, and these results provide a new insight in the study of human gastric cancer metastasis.


    Introduction
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 
Gastric cancer has been a major cause of cancer death (1) . Scirrhous gastric cancer, a diffusely infiltrating type of poorly differentiated gastric cancer, affects younger patients and has the highest mortality of all gastric cancers. Common features of scirrhous gastric cancer include invasive progression, remarkable fibrosis, and a high frequency of metastasis to peritoneum or lymph nodes (2) . Among these malignant characteristics of scirrhous gastric cancer cells, metastasis to the peritoneum or lymph nodes is an especially complex phenomenon that requires the involvement of many different genes in multiple steps for both tumor cells and the surrounding stromal cells.

Although aspects of gastric cancer metastasis remain to be elucidated, adhesion molecules have been reported to play a pivotal role. For example, decreased expression of E-cadherin, which mediates cell to cell adhesion, is correlated with the metastatic or invasive phenotype of gastric cancer cells (3) . Another adhesion molecule, integrin, which mediates cell to cell and cell to matrix adhesion, has also been known for its involvement in the peritoneal dissemination of gastric cancer cells; the ß1 subunit of integrin was reported to be a promoter (4) , and the ß4 subunit was reported to be a suppressor (5) . Apoptosis-related genes such as BAG-1, the Bcl-2 family gene, were reported to promote peritoneal dissemination of gastric cancer cells through an antiapoptotic effect (6) . {alpha}-1,3-Fucosyltransferase modifies cell surface glycan and facilitates cancer cell adhesion to the peritoneum via the E-selectin system (7) .

Previously, Yashiro et al. (8) and Fujihara et al. (9) have established OCUM-2MD3 cells (8) , which have a high potential for peritoneal dissemination when injected i.p. in a nude mice model, and OCUM-2MLN cells (9) , which have a high potential for metastasis to lymph nodes when implanted orthotopically in a nude mice model, from scirrhous gastric cancer cell line OCUM-2M to investigate the mechanism of gastric cancer metastasis. OCUM-2MD3 and OCUM-2MLN cells are the established models to study peritoneal dissemination and lymph node metastasis, respectively, and have been studied extensively both in vitro and in vivo. This model has been applied to describe the promotive effects of CD44H (10) , integrin ß1 (4 , 11) , and factors produced by cocultured fibroblasts (12) in peritoneal dissemination.

Multiple genes are involved coordinately in metastasis, whereas only one gene or a few genes have been considered in most previous reports on metastasis. Moreover, differences in metastatic potential are expected to be due to a combination of differently expressed genes. In this context, gene expression analysis of scirrhous gastric cancer cells with different metastatic potentials in terms of grade and target is extremely relevant to clarify the mechanism of gastric cancer metastasis. In this study, we globally analyzed expression profiles of approximately 6800 genes in OCUM-2M, OCUM-2MD3, and OCUM-2MLN cells by using a high-density oligonucleotide array. By combining this analysis with subsequent confirmation of altered expression in selected genes by Northern blot analysis, we identified differently expressed genes among these cells. Although further functional analysis is necessary, these results will give new insight on the elucidation of the mechanism of gastric cancer metastasis.


    Materials and Methods
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 
Cell Culture and RNA Preparation.
OCUM-2M, OCUM-2MD3, and OCUM-2MLN were established previously by Yashiro et al. (8) and Fujihara et al. (9) . GT3TKB, MKN7, MKN45, and MKN74 were purchased from Riken Cell Bank (Tsukuba, Japan). NUGC-3 and NUGC-4 were purchased from Health Science Research Resources Bank (Osaka, Japan). OCUM-2M, OCUM-2MD3, OCUM-2MLN, and GT3TKB were maintained at 37°C in a humidified atmosphere of 5% CO2 in high-glucose DMEM (Sigma, St. Louis, MO), whereas MKN7, MKN45, MKN74, NUGC-3, and NUGC-4 were maintained in RPMI 1640 (Sigma). Both media were supplemented with 10% fetal bovine serum, penicillin, and streptomycin. When they reached 80–90% confluence, cells were washed with ice-cold PBS and homogenized immediately in Isogen reagent (Nippon Gene, Osaka, Japan). Total RNA was extracted according to the manufacturer’s instructions. Polyadenylated RNA was purified from total RNA by Oligotex-(dT)30 mRNA purification kit (Takara, Osaka, Japan) and enriched by Microcon-100 (Millipore, Bedford, MA).

High-Density Oligonucleotide Array Analysis.
One µg of polyadenylated RNA from OCUM-2M, OCUM-2MD3, and OCUM-2MLN was amplified up to approximately 100 µg of cRNA and hybridized to the high-density oligonucleotide array (GeneChip HuGeneFL array; Affymetrix, Santa Clara, CA) as described previously (13) . Intensity for each feature of the array was calculated by using Affymetrix GeneChip version 3.3 software with class ABC mask file. This so-called mask file is designed to exclude inappropriate probe pairs and probe sets, which represent introns or reverse sequences. Average intensity was made equal to target intensity, which was set to 100, to reliably compare variable multiple arrays. In calculating the change of average difference, normalization for all probe sets was performed.

RT-PCR.3
cDNA was synthesized in 20 µl of reaction volume from 5 µg of total RNA using SuperScript Preamplification System for First Strand cDNA synthesis system (Life Technologies, Inc., Rockville, MD) and oligodeoxythymidylic acid primer and diluted up to 80 µl. PCR was then performed with 1 µl of cDNA for 1 cycle of 94°C for 2 min, followed by 35 cycles of 94°C for 30 s and 68°C for 3 min using the primers listed in Table 1Citation and Advantage cDNA polymerase mixture (Clontech, Palo Alto, CA). Amplification of the right target DNA was confirmed by mobility on gel electrophoresis and sequencing after subcloning into pGEM-T easy vector (Promega, Madison, WI).


View this table:
[in this window]
[in a new window]

 
Table 1 Primer pairs used in RT-PCR

 
Northern Blot Analysis.
Inserts of sequence-verified subclones were amplified by PCR using primers for T7 (5'-TAATACGACTCACTATAGG-3') and SP6 (NOREF>5'-GCTATTTAGGTGACA CTATAG-3') on vector sequence. cDNA fragments for probe were obtained by gel purification of amplified PCR products. Twenty µg of total RNA were denatured and separated by electrophoresis on a 1% agarose gel containing 2.2 M formaldehyde. Equal amount of loading was confirmed by ethidium bromide staining. The gels were blotted to Hybond XL nylon membranes (Amersham Pharmacia Biotech, Piscataway, NJ), which were hybridized to [{alpha}-32P]dCTP-labeled, random-primed cDNA fragments. Hybridization was performed by using ExpressHyb hybridization solution mixture (Clontech) according to the manufacturer’s instructions. The filters were exposed to a BAS imaging plate overnight and visualized by using a BAS1800 imaging scanner (Fujifilm, Tokyo, Japan). Signals were quantified by ImageGauge software version 3.1 (Fujifilm).


    Results
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 
Global Gene Expression Analysis of Scirrhous Gastric Cancer Cells by High-Density Oligonucleotide Array.
We first performed a global analysis of gene expression of 6800 genes in OCUM-2M, OCUM-2MD3, and OCUM-2MLN cells using high-density oligonucleotide array and compared the gene expression profiles of OCUM-2MD3 and OCUM-2MLN with that of OCUM-2M. To eliminate data with low reliability, genes whose expression was regarded as absent in both cell lines by software analysis were excluded. There were 2680 and 2815 remaining genes in OCUM-2MD3 and OCUM-2MLN, respectively. As shown in Fig. 1ACitation , OCUM-2MD3 showed broader of differently expressed genes in terms of fold change than OCUM-2MLN. Among the 2680 and 2815 genes expressed, 63 and 23 genes showed a differential expression level greater than 4-fold in OCUM-2MD3 and OCUM-2MLN, respectively. To verify the data, we then performed Northern blot analysis of 100 genes in total, including 86 genes that showed greater than 4-fold difference by oligonucleotide array. When changes greater than 2-fold in expression level by Northern blot analysis are considered significant, consistency with oligonucleotide array analysis was 49% (42 of 86), whereas no significant change was seen in 22% (19 of 86), discordant results were seen in 22% (19 of 86), and undetectable by Northern blot analysis in two cell lines compared in 7% (6 of 86). Genes concordant in both analyses are listed in Table 2Citation , and representative probe tilings after hybridization are shown in Fig. 1BCitation . We obtained discordant results with genes that showed elevated expression level in OCUM-2MD3 and OCUM-2MLN by oligonucleotide array; the ratio of concordance was 70% (25 of 36) for down-regulated genes and 34% (17 of 50) for up-regulated genes in OCUM-2MD3 and OCUM-2MLN.



View larger version (79K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 1. High-density oligonucleotide array analysis. A, histogram analysis of the fold change in gene expression in OCUM-2MD3 and OCUM-2MLN compared with OCUM-2M. Note the number of genes shown in logarithmic scale. B, representative probe tilings after hybridization. The top panels represent perfectly matched probes, and the bottom panels represent corresponding mismatched probes.

 

View this table:
[in this window]
[in a new window]

 
Table 2 Genes that showed differential expression level in OCUM-2MD3 and OCUM-2MLN compared to OCUM-2M

GenBank accession number, fold change verified by high-density oligonucleotide array and Northern blot, and one representative function of the genes as previously reported are described. Only the genes that showed expression change greater than 4-fold by oligonucleotide array and greater than 2-fold by Northern blot are listed, and genes are sorted by Northern blot data.

 
Genes Expressed Differently in OCUM-2MD3 and OCUM-2MLN Compared with OCUM-2M.
When gene expression level in OCUM-2M and OCUM-2MD3 was compared, 12 genes showed elevated expression, and 20 genes showed reduced expression in OCUM-2MD3 (Table 2)Citation . Up-regulated genes could be classified by function as follows: 4 genes for immunity, 2 genes for trefoil factor, which is a growth factor specific to the digestive tract, and 2 genes for adhesion. On the other hand, down-regulated genes could be classified as follows: 6 genes for differentiation marker of squamous cell lineage, 2 genes for cancer antigen, 2 genes for insulin-like growth factor protein, 1 gene for apoptosis, 1 gene for extracellular matrix, and 1 gene for the candidate tumor suppressor gene. Squamous cell differentiation marker gene SPRR2A, one of the SPRR family genes, was also down-regulated in OCUM-2MD3, as verified only by Northern blot analysis (Fig. 2A)Citation .



View larger version (31K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 2. Northern blot analysis of two gene clusters. OCUM-2M, OCUM-2MD3, and OCUM-2MLN were analyzed. A, genes related to differentiation of squamous cells were coordinately down-regulated in OCUM-2MD3. B, genes involved in antigen presentation were coordinately up-regulated in OCUM-2MLN.

 
On comparison of OCUM-2M and OCUM-2MLN, five genes showed a high expression level, and five genes showed a low expression level in OCUM-2MLN (Table 2)Citation . All five of the up-regulated genes were MHC class II molecules or MHC class II accessory molecules. MHC class II-DMß was also up-regulated in OCUM-2MLN, as verified only by Northern blot (Fig. 2B)Citation . Because transcription of MHC class II genes and invariant chain gene is known to be regulated quantitatively by MHC class II transactivator CIITA (14) , we next investigated whether expression of CIITA is up-regulated in OCUM-2MLN cells. CIITA was not detectable by Northern blot analysis because of its low expression level, but the expression level of CIITA was relatively higher by RT-PCR in OCUM-2MLN than in OCUM-2M cells (Fig. 3)Citation .



View larger version (39K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 3. RT-PCR analysis of CIITA. OCUM-2M, OCUM-2MD3, and OCUM-2MLN were analyzed. The highest level of expression is detected in OCUM-2MLN. G3PDH was shown as an internal control. Control and Marker represent the negative control and {phi}X174–HaeIII, respectively.

 
We observed that several genes were down-regulated in both OCUM-2MD3 cells and OCUM-2MLN cells. In addition to SPRR1A and SPRR1B, squamous cell differentiation markers such as SPRR2A, annexin A1, and EMP1 also showed reduced expression in OCUM-2MLN cells, although to a lesser extent than that seen in OCUM-2MD3 cells (Fig. 2A)Citation . Integrin ß4 and E-cadherin, which play crucial roles in peritoneal dissemination and invasion of gastric cancer, respectively, were also down-regulated in both cell lines, as verified by Northern blot analysis (Fig. 4)Citation .



View larger version (28K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 4. Representative Northern blot analysis of differentially expressed genes. Nine gastric cancer cell lines were analyzed. The potential for peritoneal dissemination in a nude mice model as reported elsewhere was also described by + (high potential), - (very low or no potential), or U (unknown potential). G3PDH was shown as an internal control.

 
Expression of Selected Genes in Nine Gastric Cancer Cell Lines.
Because several reports have previously described peritoneal dissemination potentials of other gastric cancer cell lines, we also investigated the expression of the genes differentially expressed between OCUM-2M and OCUM-2MD3 by Northern blot on another six gastric cancer cell lines, in addition to the three cell lines analyzed here, to find any correlation between these genes and the peritoneal dissemination potential of gastric cancer cells (Fig. 4)Citation . MKN45 and MKN74 have been widely used as a peritoneal dissemination model in nude mice (6 , 15) , with a higher potential for peritoneal dissemination reported in MKN45 (7) . Ishii et al. (5) reported that after injection of 5 x 106 cells of MKN7, MKN74, and MKN45 into the peritoneal cavity of severe combined immunodeficient mice, 2.3, 41.8, and 149.5 peritoneal nodules were formed, respectively. NUGC-4 is reported to induce peritoneal metastasis, leading to severe carcinomatous peritonitis, whereas NUGC-3 did not form a peritoneal metastasis even at 4 weeks after inoculation (16) . No colony of peritoneal dissemination was observed when 1 x 107 OCUM-2MLN cells were injected i.p.4

Taken together, these cells can be readily classified into two groups: (a) cells with a high potential for peritoneal dissemination (OCUM-2MD3, MKN45, MKN74, and NUGC-4); and (b) cells with low potential or no potential for peritoneal dissemination (OCUM-2M, OCUM-2MLN, MKN7, and NUGC-3). Although there are no reports on the peritoneal dissemination potential of GT3TKB in the nude mice system, we included it in our study because it is one of the cell lines derived from disseminated nodules on the peritoneum. Trefoil factor 1, {alpha}-1-antitrypsin, and galectin 4 showed a high expression level only in cells with a high potential for peritoneal dissemination and a low expression level in all of the cells with a low potential for peritoneal dissemination. On the contrary, cytidine deaminase showed a reciprocal expression pattern. The expression pattern of integrin ß4 and E-cadherin did not show any correlation to peritoneal dissemination potential.


    Discussion
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 
With regard to peritoneal dissemination, malignant characteristics of cancer cells such as decreased intercellular adhesion, increased cell to matrix adhesion, and resistance to apoptosis have been considered to be important. Several of the 32 genes that showed different expression levels in OCUM-2M and OCUM-2MD3 in this study have been reported previously to have a relationship with these features. For example, {alpha}-1,3-fucosyltransferase, which is essential for sialyl-Le(X) and sialyl-Le(A) antigen, is reported to be expressed in the peritoneum, to facilitate the attachment of cancer cells to the peritoneum, and to promote liver metastasis of some cancers via E-selectin-mediated adhesion (7 , 17) . Trefoil factors 1 and 3, growth factors of the gastrointestinal tract that play pivotal roles in restitution after mucosal injury, are reported to promote cell growth and motility as well as down-regulate E-cadherin expression (18 , 19) . As a result, autocrine production of these growth factors by cancer cells could be highly advantageous to invasion and metastasis. Bik induces apoptosis by interacting with Bcl-2 (20) . Decreased expression of Bik might prolong cell survival, thereby promoting peritoneal dissemination because overexpression of BAG-1, a Bcl-2 family gene, can lead to enhanced peritoneal dissemination of gastric cancer through an antiapoptotic effect (6) . Without laminin {gamma}1, which makes a heterotrimer with other {alpha} and ß subunits, mature laminin is not produced, leading to a complete absence of the basement membrane (21) . It is reported that decreased expression of laminin, as often seen in various gastric cancer cell lines, causes basement membrane fragility (22) . Thus, reduced expression of laminin {gamma}1 might facilitate tumor invasion by concomitant incomplete barrier formation. IQGAP1, a negative regulator of E-cadherin-mediated cell to cell adhesion (23) , was down-regulated. A recent study (24) reported that gastric hyperplasia are observed in the IQGAP1(-/-) mouse, suggesting another function of IQGAP1 in relation to overgrowth. In this context, reduced expression of IQGAP1 might involve cell proliferation rather than reduced negative regulation of cell to cell adhesion.

Down-regulation of the squamous cell differentiation marker gene cluster in OCUM-2MD3 was obvious. Squamous cell differentiation marker included cornified envelope-related genes, CRABP2, and mesothelin. SPRR1A, SPRR1B, SPRR2A, and annexin A1 are all major constituents (25) , and EMP1 was reported to be coexpressed with these four genes (26) . Cornified envelope is observed only in squamous cells such as differentiated keratinocytes, but we could detect expression of one of the cornified envelope-related genes, SPRR1B, in adenocarcinoma cell lines that originated from the breast, pancreas, and colon (data not shown), therefore suggesting possible different roles for this gene cluster other than cornification. Interestingly, these cornified envelope-related genes were also down-regulated in OCUM-2MLN. Thus, reduction of cornification-related genes might have a function that is relevant in metastasis. Coordinate decreased expression of these functionally related genes implicates an upstream regulator; one possible regulator is retinoid because cornified envelope genes are reported to be suppressed by retinoic acid (27) , and CRABP2 mediates retinoic acid signal transduction (28) . Another cell surface marker, mesothelin, which is literally a differentiation marker of mesothelium that covers the peritoneum, regulates the traffic of molecules and cells in and out of the peritoneal cavity (29) . It is probable that reduced expression of mesothelin can alter the adhesiveness of cancer cells to the peritoneum, although there is limited information on the matter of this gene function.

On the other hand, in gastric cancer cell lines with a high potential for peritoneal dissemination such as MKN45, MKN74, NUGC-4, and OCUM-2MD3, there was a tendency for galectin 4, {alpha}-1-antitrypsin, and trefoil factor 1 to show a high expression level and for cytidine deaminase to show a low expression level. Whether these genes are involved in peritoneal dissemination is a matter to be further investigated.

Up-regulation of MHC class II genes and invariant chain gene in OCUM-2MLN was extremely intriguing. Expression of these antigen gene clusters is often observed in a solid tumor, although its significance to cancer cells is unclear. It was reported that on the surface of OCUM-2M and OCUM-2MLN cells, MHC class II antigens were not detected by flow cytometry analysis at all (9) , suggesting that these molecules may not be functionally intact or stable. Transcription of MHC class II genes and invariant chain gene has been considered to be regulated by MHC class II transactivator CIITA constitutively in B cells or dendritic cells and inducibly by IFN-{gamma} in nonlymphoid tissues (30 , 31) . In addition, the expression level of CIITA was reported to be proportional to that of MHC class II genes (14) . In this study, a higher expression level of CIITA was seen by RT-PCR in OCUM-2MLN as compared with OCUM-2M, as predicted. When analyzed by oligonucleotide array, differential expression of CIITA between both cell lines was not reliably detected, presumably because of a subtle change within a low expression level. However, we could finally detect the difference by deducing an upstream regulator gene from the expression profile analysis. We believe that this is also an effective way to make use of array technology and that the sensitivity of array technology must be improved in the future. E-cadherin and integrin ß4, genes relevant for gastric cancer metastasis, were down-regulated in both of the metastatic sublines of OCUM-2M. E-cadherin is regarded as an invasion suppressor in gastric cancer and other types of cancer (3) , and integrin ß4 has recently been reported as a suppressor of peritoneal dissemination of gastric cancer (5) . Suppressed expression of these genes in the highly metastatic cells, as we have shown in this study, is in good concordance with previous reports and indicates that gene expression change in these cells properly reflects some metastatic characteristics. In this study, however, these genes showed various expression patterns among nine gastric cancer cell lines, and no apparent correlation was observed with peritoneal dissemination potential. These results clearly show that a complex phenomenon in vivo such as peritoneal dissemination cannot be explained by altered expression of a single gene. Thus, the relevance of exploring the global gene expression profile by using a comprehensive procedure is obvious.

Although the initial discrepancy between the data by high-density oligonucleotide array and the data by Northern blot was not negligible in this study, the final data presented here were verified by two different methods and must be highly reliable. Oligonucleotide array analysis greatly facilitated clarification of a whole aspect of gastric cancer metastasis by showing the global changes in gene expression and revealing two differently regulated gene clusters, which have not been reported in relation to metastasis. Based on this study, further investigations are now required for all of the genes discussed above to verify their involvement in peritoneal dissemination and lymph node metastasis.


    ACKNOWLEDGMENTS
 
We thank S. Fukui and E. Fujita for technical assistance and Y. H. Kim for critical review of the manuscript.


    FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported in part by Grants in Aid for Scientific Research (B) 09557014 and 10470131 and for Scientific Research on Priority Areas (C) 12217031 from the Ministry of Education, Science, Sports and Culture (to H. A.). Back

2 To whom requests for reprints should be addressed, at Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8904, Japan. Phone: 81-3-5452-5235; Fax: 81-3-5452-5355; E-mail: haburata-tky{at}umin.ac.jp Back

3 The abbreviations used are: RT-PCR, reverse transcription-PCR; G3PDH, glyceraldehyde-3-phosphate dehydrogenase; IQGAP1, IQ motif containing GTPase-activating protein 1; SPRR, small proline-rich protein; CRABP2, cellular retinoic acid-binding protein 2; EMP1, epithelial membrane protein 1. Back

4 M. Yashiro, unpublished data. Back

Received 6/14/00. Accepted 11/29/00.


    REFERENCES
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 

  1. Howson C. P., Hiyama T., Wynder E. L. The decline in gastric cancer: epidemiology of an unplanned triumph.. Epidemiol. Rev., 8: 1-27, 1986.[Free Full Text]
  2. Yokota T., Teshima S., Saito T., Kikuchi S., Kunii Y., Yamauchi H. Borrmann’s type IV gastric cancer: clinicopathologic analysis.. Can. J. Surg., 42: 371-376, 1999.[Medline]
  3. Christofori G., Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene.. Trends Biochem. Sci., 24: 73-76, 1999.[Medline]
  4. Nishimura S., Chung Y. S., Yashiro M., Inoue T., Sowa M. Role of {alpha}2ß1- and {alpha}3ß1-integrin in the peritoneal implantation of scirrhous gastric carcinoma.. Br. J. Cancer, 74: 1406-1412, 1996.[Medline]
  5. Ishii Y., Ochiai A., Yamada T., Akimoto S., Yanagihara K., Kitajima M., Hirohashi S. Integrin {alpha}6ß4 as a suppressor and a predictive marker for peritoneal dissemination in human gastric cancer.. Gastroenterology, 118: 497-506, 2000.[Medline]
  6. Yawata A., Adachi M., Okuda H., Naishiro Y., Takamura T., Hareyama M., Takayama S., Reed J. C., Imai K. Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells.. Oncogene, 16: 2681-2686, 1998.[Medline]
  7. Asao T., Nagamachi Y., Morinaga N., Shitara Y., Takenoshita S., Yazawa S. Fucosyltransferase of the peritoneum contributed to the adhesion of cancer cells to the mesothelium.. Cancer (Phila.), 75: 1539-1544, 1995.[Medline]
  8. Yashiro M., Chung Y. S., Nishimura S., Inoue T., Sowa M. Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice.. Clin. Exp. Metastasis, 14: 43-54, 1996.[Medline]
  9. Fujihara T., Sawada T., Hirakawa K., Chung Y. S., Yashiro M., Inoue T., Sowa M. Establishment of lymph node metastatic model for human gastric cancer in nude mice and analysis of factors associated with metastasis.. Clin. Exp. Metastasis, 16: 389-398, 1998.[Medline]
  10. Nishimura S., Chung Y. S., Yashiro M., Inoue T., Sowa M. CD44H plays an important role in peritoneal dissemination of scirrhous gastric cancer cells.. Jpn. J. Cancer Res., 87: 1235-1244, 1996.[Medline]
  11. Matsuoka T., Hirakawa K., Chung Y. S., Yashiro M., Nishimura S., Sawada T., Saiki I., Sowa M. Adhesion polypeptides are useful for the prevention of peritoneal dissemination of gastric cancer.. Clin. Exp. Metastasis, 16: 381-388, 1998.[Medline]
  12. Nishimura S., Hirakawa-Chung K. Y., Yashiro M., Inoue T., Matsuoka T., Fujihara T., Murahashi K., Sawada T., Nakata B., Jikihara I., Takagi H., Sowa M. TGF-ß1 produced by gastric cancer cells affects mesothelial cell morphology in peritoneal dissemination.. Int. J. Oncol., 12: 847-851, 1998.[Medline]
  13. Ishii M., Hashimoto S., Tsutsumi S., Wada Y., Matsushima K., Kodama T., Aburatani H. Direct comparison of GeneChip and SAGE on the quantitative accuracy in transcript profiling analysis.. Genomics, 68: 136-143, 2000.[Medline]
  14. Otten L. A., Steimle V., Bontron S., Mach B. Quantitative control of MHC class II expression by the transactivator CIITA.. Eur. J. Immunol., 28: 473-478, 1998.[Medline]
  15. Okamoto K., Yamaguchi T., Otsuji E., Yamaoka N., Yata Y., Tsuruta H., Kitamura K., Takahashi T. Targeted chemotherapy in mice with peritoneally disseminated gastric cancer using monoclonal antibody-drug conjugate.. Cancer Lett., 122: 231-236, 1998.[Medline]
  16. Nakashio T., Narita T., Akiyama S., Kasai Y., Kondo K., Ito K., Takagi H., Kannagi R. Adhesion molecules and TGF-ß1 are involved in the peritoneal dissemination of NUGC-4 human gastric cancer cells.. Int. J. Cancer, 70: 612-618, 1997.[Medline]
  17. Weston B. W., Hiller K. M., Mayben J. P., Manousos G. A., Bendt K. M., Liu R., Cusack J. C., Jr. Expression of human {alpha}-1,3-fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells.. Cancer Res., 59: 2127-2135, 1999.[Abstract/Free Full Text]
  18. Efstathiou J. A., Noda M., Rowan A., Dixon C., Chinery R., Jawhari A., Hattori T., Wright N. A., Bodmer W. F., Pignatelli M. Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells.. Proc. Natl. Acad. Sci. USA, 95: 3122-3127, 1998.[Abstract/Free Full Text]
  19. Podolsky D. K. Mechanisms of regulatory peptide action in the gastrointestinal tract: trefoil peptides.. J. Gastroenterol., 35(Suppl.12): 69-74, 2000.
  20. Boyd J. M., Gallo G. J., Elangovan B., Houghton A. B., Malstrom S., Avery B. J., Ebb R. G., Subramanian T., Chittenden T., Lutz R. J., et al Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins.. Oncogene, 11: 1921-1928, 1995.[Medline]
  21. Smyth N., Vatansever H. S., Murray P., Meyer M., Frie C., Paulsson M., Edgar D. Absence of basement membranes after targeting the LAMC1 gene results in embryonic lethality due to failure of endoderm differentiation.. J. Cell Biol., 144: 151-160, 1999.[Abstract/Free Full Text]
  22. Akashi T., Miyagi T., Ando N., Suzuki Y., Nemoto T., Eishi Y., Nakamura K., Shirasawa T., Osa N., Tanaka N., Burgeson R. E. Synthesis of basement membrane by gastrointestinal cancer cell lines.. J. Pathol., 187: 223-228, 1999.[Medline]
  23. Kuroda S., Fukata M., Nakagawa M., Fujii K., Nakamura T., Ookubo T., Izawa I., Nagase T., Nomura N., Tani H., Shoji I., Matsuura Y., Yonehara S., Kaibuchi K. Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin-mediated cell-cell adhesion.. Science (Washington DC), 281: 832-835, 1998.[Abstract/Free Full Text]
  24. Li S., Wang Q., Chakladar A., Bronson R. T., Bernards A. Gastric hyperplasia in mice lacking the putative Cdc42 effector IQGAP1.. Mol. Cell. Biol., 20: 697-701, 2000.[Abstract/Free Full Text]
  25. Robinson N. A., Lapic S., Welter J. F., Eckert R. L. S100A11, S100A10, annexin I, desmosomal proteins, small proline-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes.. J. Biol. Chem., 272: 12035-12046, 1997.[Abstract/Free Full Text]
  26. Marvin K. W., Fujimoto W., Jetten A. M. Identification and characterization of a novel squamous cell-associated gene related to PMP22.. J. Biol. Chem., 270: 28910-28916, 1995.[Abstract/Free Full Text]
  27. Hohl D., de Viragh P. A., Amiguet-Barras F., Gibbs S., Backendorf C., Huber M. The small proline-rich proteins constitute a multigene family of differentially regulated cornified cell envelope precursor proteins.. J. Investig. Dermatol., 104: 902-909, 1995.[Medline]
  28. Dong D., Ruuska S. E., Levinthal D. J., Noy N. Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid.. J. Biol. Chem., 274: 23695-23698, 1999.[Abstract/Free Full Text]
  29. Chang K., Pastan I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.. Proc. Natl. Acad. Sci. USA, 93: 136-140, 1996.[Abstract/Free Full Text]
  30. Steimle V., Siegrist C. A., Mottet A., Lisowska-Grospierre B., Mach B. Regulation of MHC class II expression by interferon-{gamma} mediated by the transactivator gene CIITA.. Science (Washington DC), 265: 106-109, 1994.[Abstract/Free Full Text]
  31. Steimle V., Otten L. A., Zufferey M., Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).. Cell, 75: 135-146, 1993.[Medline]



This article has been cited by other articles:


Home page
Cancer Res.Home page
J. Santos, L. Gonzalez-Sanchez, M. Matabuena-deYzaguirre, M. Villa-Morales, P. Cozar, P. Lopez-Nieva, P. Fernandez-Navarro, M. Fresno, M. D. Diaz-Munoz, J.-L. Guenet, et al.
A Role for Stroma-Derived Annexin A1 as Mediator in the Control of Genetic Susceptibility to T-Cell Lymphoblastic Malignancies through Prostaglandin E2 Secretion
Cancer Res., March 15, 2009; 69(6): 2577 - 2587.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Koide, T. Yamada, R. Shibata, T. Mori, M. Fukuma, K. Yamazaki, K. Aiura, M. Shimazu, S. Hirohashi, Y. Nimura, et al.
Establishment of Perineural Invasion Models and Analysis of Gene Expression Revealed an Invariant Chain (CD74) as a Possible Molecule Involved in Perineural Invasion in Pancreatic Cancer
Clin. Cancer Res., April 15, 2006; 12(8): 2419 - 2426.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. K. Dhar, T. C. Wang, H. Tabara, Y. Tonomoto, R. Maruyama, M. Tachibana, H. Kubota, and N. Nagasue
Expression of Trefoil Factor Family Members Correlates with Patient Prognosis and Neoangiogenesis
Clin. Cancer Res., September 15, 2005; 11(18): 6472 - 6478.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Sakakura, K. Hasegawa, K. Miyagawa, S. Nakashima, T. Yoshikawa, S. Kin, Y. Nakase, S. Yazumi, H. Yamagishi, T. Okanoue, et al.
Possible Involvement of RUNX3 Silencing in the Peritoneal Metastases of Gastric Cancers
Clin. Cancer Res., September 15, 2005; 11(18): 6479 - 6488.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Yokokawa, C. Palena, P. Arlen, R. Hassan, M. Ho, I. Pastan, J. Schlom, and K. Y. Tsang
Identification of Novel Human CTL Epitopes and Their Agonist Epitopes of Mesothelin
Clin. Cancer Res., September 1, 2005; 11(17): 6342 - 6351.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Li, P. Kessler, H. Yeger, J. Alami, A. E. Reeve, R. Heathcott, J. Skeen, and B. R.G. Williams
A Gene Expression Signature for Relapse of Primary Wilms Tumors
Cancer Res., April 1, 2005; 65(7): 2592 - 2601.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S.-i. Fukumoto, N. Yamauchi, H. Moriguchi, Y. Hippo, A. Watanabe, J. Shibahara, H. Taniguchi, S. Ishikawa, H. Ito, S. Yamamoto, et al.
Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokers' Non-Small Cell Lung Carcinomas
Clin. Cancer Res., March 1, 2005; 11(5): 1776 - 1785.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Rump, Y. Morikawa, M. Tanaka, S. Minami, N. Umesaki, M. Takeuchi, and A. Miyajima
Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion
J. Biol. Chem., March 5, 2004; 279(10): 9190 - 9198.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. M. Garcia Pedrero, M. P. Fernandez, R. O. Morgan, A. Herrero Zapatero, M. V. Gonzalez, C. Suarez Nieto, and J. P. Rodrigo
Annexin A1 Down-Regulation in Head and Neck Cancer Is Associated with Epithelial Differentiation Status
Am. J. Pathol., January 1, 2004; 164(1): 73 - 79.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Watanabe, Y. Hippo, H. Taniguchi, H. Iwanari, M. Yashiro, K. Hirakawa, T. Kodama, and H. Aburatani
An Opposing View on WWOX Protein Function as a Tumor Suppressor
Cancer Res., December 15, 2003; 63(24): 8629 - 8633.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Kim, S. Bang, S. Lee, S. Kim, Y. Jung, C. Lee, K. Choi, S.-G. Lee, K. Lee, Y. Lee, et al.
Expression Profiling and Subtype-Specific Expression of Stomach Cancer
Cancer Res., December 1, 2003; 63(23): 8248 - 8255.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. T. Tay, S. H. Leong, K. Yu, A. Aggarwal, S. Y. Tan, C. H. Lee, K. Wong, J. Visvanathan, D. Lim, W. K. Wong, et al.
A Combined Comparative Genomic Hybridization and Expression Microarray Analysis of Gastric Cancer Reveals Novel Molecular Subtypes
Cancer Res., June 15, 2003; 63(12): 3309 - 3316.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Suyama, H. Kawasaki, T. Kasaoka, and K. Taira
Identification of Genes Responsible for Cell Migration by a Library of Randomized Ribozymes
Cancer Res., January 1, 2003; 63(1): 119 - 124.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Hasegawa, Y. Furukawa, M. Li, S. Satoh, T. Kato, T. Watanabe, T. Katagiri, T. Tsunoda, Y. Yamaoka, and Y. Nakamura
Genome-Wide Analysis of Gene Expression in Intestinal-Type Gastric Cancers Using a Complementary DNA Microarray Representing 23,040 Genes
Cancer Res., December 1, 2002; 62(23): 7012 - 7017.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. L. Dennis, J. K. Vass, E. C. Wit, W. N. Keith, and K. A. Oien
Identification from Public Data of Molecular Markers of Adenocarcinoma Characteristic of the Site of Origin
Cancer Res., November 1, 2002; 62(21): 5999 - 6005.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J.-M. Chong, K. Sakuma, M. Sudo, T. Osawa, E. Ohara, H. Uozaki, J. Shibahara, K. Kuroiwa, S.-i. Tominaga, Y. Hippo, et al.
Interleukin-1{beta} Expression in Human Gastric Carcinoma with Epstein-Barr Virus Infection
J. Virol., June 5, 2002; 76(13): 6825 - 6831.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Yamachika, J. L. Werther, C. Bodian, M. Babyatsky, M. Tatematsu, Y. Yamamura, A. Chen, and S. Itzkowitz
Intestinal Trefoil Factor: A Marker of Poor Prognosis in Gastric Carcinoma
Clin. Cancer Res., May 1, 2002; 8(5): 1092 - 1099.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
H. Ideo, A. Seko, T. Ohkura, K. L. Matta, and K. Yamashita
High-affinity binding of recombinant human galectin-4 to SO3-->3Gal{beta}1->3GalNAc pyranoside
Glycobiology, March 1, 2002; 12(3): 199 - 208.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
R. Todd and D.T.W. Wong
DNA Hybridization Arrays for Gene Expression Analysis of Human Oral Cancer
Journal of Dental Research, February 1, 2002; 81(2): 89 - 97.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Hippo, H. Taniguchi, S. Tsutsumi, N. Machida, J.-M. Chong, M. Fukayama, T. Kodama, and H. Aburatani
Global Gene Expression Analysis of Gastric Cancer by Oligonucleotide Microarrays
Cancer Res., January 1, 2002; 62(1): 233 - 240.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hippo, Y.
Right arrow Articles by Aburatani, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hippo, Y.
Right arrow Articles by Aburatani, H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online